Casdin Capital, LLC Q3 2016 Filing
Filed November 14, 2016
Portfolio Value
$123.5B
Holdings
26
Report Date
Q3 2016
Filing Type
13F-HR
All Holdings (26 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | AGIOAGIOS PHARMACEUTICALS INC | 282,443 | $14.9B | 12.08% | |
| 2 | SG7SAGE THERAPEUTICS INC | 266,500 | $12.3B | 9.94% | |
| 3 | —FOUNDATION MEDICINE INC | 415,000 | $9.7B | 7.85% | |
| 4 | EVHEVOLENT HEALTH INC | 385,000 | $9.5B | 7.68% | |
| 5 | 2L9BLUEPRINT MEDICINES CORP | 287,000 | $8.5B | 6.90% | |
| 6 | —LOXO ONCOLOGY INC | 291,000 | $7.6B | 6.17% | |
| 7 | —GENMARK DIAGNOSTICS INC | 625,000 | $7.4B | 5.97% | |
| 8 | —SPARK THERAPEUTICS INC | 93,500 | $5.6B | 4.55% | |
| 9 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 240,000 | $5.5B | 4.48% | |
| 10 | —KITE PHARMA INC | 90,000 | $5.0B | 4.07% | |
| 11 | —BLUEBIRD BIO INC | 60,000 | $4.1B | 3.29% | |
| 12 | CLVSEURCLOVIS ONCOLOGY INC | 110,000 | $4.0B | 3.21% | |
| 13 | VYGRVOYAGER THERAPEUTICS INC | 276,500 | $3.3B | 2.69% | |
| 14 | —EPIZYME INC | 295,000 | $2.9B | 2.35% | |
| 15 | EXASEXACT SCIENCES CORP | 155,000 | $2.9B | 2.33% | |
| 16 | ALNYALNYLAM PHARMACEUTICALS INC | 39,000 | $2.6B | 2.14% | |
| 17 | MDRXALLSCRIPTS HEALTHCARE SOLUTN | 200,000 | $2.6B | 2.13% | |
| 18 | —MYOKARDIA INC | 160,000 | $2.6B | 2.12% | |
| 19 | —GENOMIC HEALTH INC | 90,000 | $2.6B | 2.11% | |
| 20 | —MEDGENICS INC | 375,000 | $2.1B | 1.69% | |
| 21 | CTMXCYTOMX THERAPEUTICS INC | 127,500 | $2.0B | 1.62% | |
| 22 | IBBISHARES TR | 5,000 | $1.4B | 1.17% | |
| 23 | —IGNYTA INC | 195,000 | $1.2B | 0.99% | |
| 24 | ISIIONIS PHARMACEUTICALS INC | 33,000 | $1.2B | 0.98% | |
| 25 | EDITEDITAS MEDICINE INC | 85,470 | $1.2B | 0.93% | |
| 26 | —SYROS PHARMACEUTICALS INC | 50,000 | $694.0M | 0.56% |